Large-scale testing (Phase 3)UnknownNCT02409199What this trial is testingApatinib Versus Docetaxol Patients With Advanced Gastric CancerWho this might be right forGastric Carcinoma Shanghai Zhongshan Hospital 66
Testing effectiveness (Phase 2)Study completedNCT01129206What this trial is testingPralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based TherapyWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinomas of the Gastroesophageal JunctionRecurrent Esophageal Cancer+2 more Ohio State University Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT03277352What this trial is testingINCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic MalignanciesWho this might be right forAdvanced MalignanciesMetastatic Cancer Incyte Biosciences International Sàrl 10
Testing effectiveness (Phase 2)Study completedNCT02830594What this trial is testingPembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction CancerWho this might be right forGastric AdenocarcinomaGastric Squamous Cell CarcinomaGastroesophageal Junction Adenocarcinoma+3 more City of Hope Medical Center 14
Early research (Phase 1)Study completedNCT03652077What this trial is testingA Safety and Tolerability Study of INCAGN02390 in Select Advanced MalignanciesWho this might be right forCervical CancerGastric CancerStomach Cancer+18 more Incyte Corporation 40
Not applicableStudy completedNCT06044961What this trial is testingRadiomics-based Models for the Prediction of Pathological Response to Neoadjuvant Therapy in Gastric and Gastroesophageal CancerWho this might be right forPatients With Locally Advanced Carcinoma of the Stomach and Oesophagogastric Junction Fondazione Policlinico Universitario Agostino Gemelli IRCCS 80
Large-scale testing (Phase 3)UnknownNCT02509286What this trial is testingPerioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the EsophagusWho this might be right forEsophageal Adenocarcinoma (UICC TNM7)Adenocarcinoma of the Esophagogastric Junction University Hospital Schleswig-Holstein 438
Early research (Phase 1)Ended earlyNCT03735290What this trial is testingEvaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced CancerWho this might be right forCarcinoma, Squamous Cell of Head and NeckGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+1 more Mendus 21
Early research (Phase 1)Active Not RecruitingNCT03132922What this trial is testingMAGE-A4ᶜ¹º³²T for Multi-TumorWho this might be right forUrinary Bladder CancerMelanomaHead and Neck Cancer+7 more USWM CT, LLC 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06666166What this trial is testingSHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal CancerWho this might be right forAdvanced Gastric CarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaAdvanced Colorectal Cancer Yunpeng Liu 28
Testing effectiveness (Phase 2)Study completedNCT00258323What this trial is testingRadiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction CancerWho this might be right forEsophageal Cancer Case Comprehensive Cancer Center 80
Testing effectiveness (Phase 2)Looking for participantsNCT06265285What this trial is testingComparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramWho this might be right forAdvanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more Mayo Clinic 50
Early research (Phase 1)Ended earlyNCT06299163What this trial is testingNM32-2668 in Adult Patients With Selected Advanced Solid TumorsWho this might be right forOvarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma+10 more Numab Therapeutics AG 11
Early research (Phase 1)Looking for participantsNCT07358806What this trial is testingStudy to Assess the Effect of OCT-598 in Patients With Advanced Solid TumorsWho this might be right forSolid TumorBreast CancerHead and Neck Cancer+3 more Oscotec Inc. 51
Early research (Phase 1)Study completedNCT06549816What this trial is testingSGN-B6A in Chinese Participants With Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckEsophageal Squamous Cell Carcinoma+3 more Seagen, a wholly owned subsidiary of Pfizer 6
Not applicableLooking for participantsNCT07283939What this trial is testingStudying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment DelaysWho this might be right forAmpulla of Vater CarcinomaAppendix CarcinomaCarcinoma of Unknown Primary With Gastrointestinal Profile+7 more Alliance for Clinical Trials in Oncology 420
Testing effectiveness (Phase 2)Study completedNCT00607594What this trial is testingSaracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the StomachRecurrent Gastric Cancer+4 more National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)WithdrawnNCT00800969What this trial is testingProspective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and StomachWho this might be right forAdenocarcinomaStomach CancerCancer of Esophagogastric Junction University of Zurich
Early research (Phase 1)Active Not RecruitingNCT05891171What this trial is testingStudy of AB598 Monotherapy and Combination Therapy in Participants With Advanced CancersWho this might be right forAdvanced CancerAdvanced MalignanciesBladder Cancer+9 more Arcus Biosciences, Inc. 40
Not applicableLooking for participantsNCT05059444What this trial is testingORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationWho this might be right forBladder CarcinomaUreter CarcinomaRenal Pelvis Carcinoma+14 more Guardant Health, Inc. 2,285